Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 242

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 242
---
banes-Oxley Act of 2002, as amended; |

| ● | reduced disclosure about                                                                                                 
 the Company’s executive compensation arrangements in its periodic reports, proxy statements and registration statements; |

| ● | exemptions from the requirements                                                                      
 of holding non-binding advisory votes on executive compensation or golden parachute arrangements; and |

| ● | an exemption from compliance                                                                                                        
 with the requirements of the Public Company Accounting Oversight Board regarding the communication of critical audit matters in the 
 auditor’s report on financial statements.                                                                                           |

The Company will cease to
qualify as an emerging growth company on the date that is the earliest of: (i) the last day of the fiscal year following the fifth
anniversary of the date of the first sale of shares of PBAX Class A Common Stock in its initial public offering, (ii) the last day
of the fiscal year in which the Company has more than $1.07 billion in total annual gross revenues, (iii) the date on which
the Company is deemed to be a “large accelerated filer” under the rules of the SEC, which means the market value of the Common
Stock that is held by non-affiliates exceeds $700.0 million as of the prior June 30th, or (iv) the date on which the Company
has issued more than $1.0 billion of non-convertible debt over the prior three-year period. The Company may choose to take advantage
of some but not all of these reduced reporting burdens. Accordingly, the information contained herein may be different than you might
obtain from other public companies.

<div align='center'>141

MANAGEMENT OF CERO</div>

Executive Officers and Directors

As of December 2, 2024, our directors and executive
officers were as follows:

| Name                   |     | Age |     | Title                                |
| Executive Officers:    |     |     |     |                                      |
| Chris Ehrlich          |     |  54 |     | Chairman and Chief Executive Officer |
| Andrew “Al” Kucharchuk |     |  44 |     | Chief Financial Officer              |
| Kristen Pierce         |     |  54 |     | Chief Development Officer            |
| Directors:             |     |     |     |                                      |
| Brian G. Atwood        |     |  72 |     | Director                             |
| Michael Byrnes         |     |  48 |     | Director                             |
| Kathleen LaPort